The coronavirus vaccine has been approved for rollout next week in the UK – but it won’t be available for everyone to begin with.
British regulators have approved the Pfizer/BioNTech Covid-19 vaccine, which scientists found offers up to 95% protection.
Britain has ordered 40million doses of the coronavirus vaccine, which is enough to vaccinate 20million people – requiring two shots each.
But Health Secretary Matt Hancock said that 80,000 doses will be available already next week.
The Joint Committee on Vaccine and Immunisation (JCVI) its due to set out its priority list later today, December 2.
However, the government has already published an “interim ranking of priorities” for the coronavirus vaccine.
This means that it’s not the end priority list, and it may change after the committee has met today.
Here is the priority list of those will receive the coronavirus vaccine, based on interim results.
1. Older adults’ resident in a care home and care home workers
2. All those 80 years of age and over and health and social care workers
3. All those 75 years of age and over
4. All those 70 years of age and over
5. All those 65 years of age and over
6. High-risk adults under 65 years of age
7. Moderate-risk adults under 65 years of age
8. All those 60 years of age and over
9. All those 55 years of age and over
10. All those 50 years of age and over
11. Rest of the population (priority to be determined)
Boris Johnson vows to free areas from Covid rules with new local Tiers
The NHS will start giving the coronavirus as soon as it’s available, which is next week.
The final decision on who will get the vaccine first will follow advice from the JCVI.
A Department of Health and Social Care spokesman said: “The Government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer/BioNTech’s Covid-19 vaccine for use."
Govt rules out 'vaccine passports' for pub trips after Covid jabs are approved
He continued: "This follows months of rigorous clinical trials and a thorough analysis of the data by experts at the MHRA who have concluded that the vaccine has met its strict standards of safety, quality and effectiveness.
“The Joint Committee on Vaccination and Immunisation (JCVI) will also publish its latest advice for the priority groups to receive the vaccine, including care home residents, health and care staff, the elderly and the clinically extremely vulnerable.
"The vaccine will be made available across the UK from next week."
Source: Read Full Article